Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icosapent ethyl in aortic valve stenosis
NCT06466278Phase 2Active, not recruiting
- Sponsor
- University of Amsterdam
- Start
- Jun 2023
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of omega-3-acid triglycerides in aortic valve stenosis (2 arms), sponsored by University of Amsterdam. Primary endpoint: Change in aortic valve calcium score at 2 years. Started Jun 2023; status: active, not recruiting.
02
Drugs
omega-3-acid triglycerides
03
Conditions
aortic valve stenosis
Beyond the preview
Go deeper on NCT06466278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06466278.